The NHS, industry, and government organizations joined together on 24th March 2022 to celebrate the UK's supportive ecosystem for Advanced Therapy Medicinal Products (ATMP), including the Highly Successful Advanced Therapy Treatment Centre Network (ATTC). There was also a discussion of the remaining barriers to clinical adoption, as outlined in the National Cell and Gene Therapy Vision for the UK.
A summary of the day's discussion is presented in this Forum Report.
Click here or the image below to view.
